CPHI vs LMT · rev $4.1M vs P/E 20, rev $75.05B
China Pharma Holdings Inc (CPHI) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
CPHI currently screens at market cap $29.0M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the CPHI and LMT stock pages for the full models.
Not investment advice.